Clinical Trial Search

Primary: Change in Progesterone Sensitivity Index Before and After Metformin Treatment. — -4.12; -4.29 % change in LH pulses/day 7 P4 level

Primary: 17-hydroxyprogesterone Responses to hCG in PCOS Women and Normal Controls — 1.3; 3; 1.1 ng/ml

Primary: 17OHP Levels After hCG — 3.2; 1.3 ng/ml

Primary: Serum 17OHP Responses to hCG — 2.0; 1.2; 1.1; 1.0 ng/ml — p=<0.05

Primary: Percent Change of 17-OHP Levels From Baseline — 67; 140 percent change

Primary: 17-hydroxyprogesterone Response to ACTH — 2.4; 3.7; 3.1; 2.9 ng/mL

Primary: Hepatic Glucose Release — 1.85; 1.46; 1.54; 1.88 mg/kg/min

Primary: Renal Clearance of D-chiroinositol (DCI) at 12 Days — 4.75; 5.16 ml/min

Primary: Biochemical Assessment of Hyperandrogenism — 0.7; 0.7 Index — p=<.0001

Primary: Live Birth Rate — 13; 5; 12 participants — p=0.06

Primary: Hepatic Fat Fraction — 8.35 Percent

Primary: Percent Change in Free Testosterone (T) — -6.9; -35.8; 12.1 percent change

Primary: Lean Body Mass — 1.8; 0.8 kilograms — p=0.04

Primary: Estradiol Level in Female Offspring — 18606; 6467 pg/ml — p=0.049

Primary: Lipid Content of PCOS Subcutaneous (SC) Abdominal Adipocytes Matured in Vitro. — 2.0; 5.6; 1.37; 3.8 fluorescence units/cell number — p=0.004